Collaboration, Licensing and Other Arrangements - Revenue Allocation (Detail) - Collaboration and License Agreement - United Therapeutics Corporation - Over Time $ in Millions |
1 Months Ended |
|---|---|
|
Dec. 31, 2022
USD ($)
| |
| R&D Services and License | |
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
| Progress Measure | Ratably |
| Recognition Period | Aug 2021 - Oct 2021 |
| Next-Gen R&D Services | |
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |
| Total transaction price | $ 10.0 |
| Progress Measure | Input |
| Recognition Period | % of completion of costs |